Divis Laboratories Ltd

NSE : DIVISLAB17 Feb 2025
Pharmaceuticals
+63.65 (+1.09%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Divis Laboratories Ltd
Divis Laboratories Ltd
Pharmaceuticals
NSE : DIVISLAB17 Feb 2025
+63.65 (+1.09%)
1D
1M
6M
1Y
5Y
All

Divis Laboratories Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
57.10%
Upper Circuit
Lower Circuit
P/E TTM
74.74
P/B Ratio
11.36
Traded Value(Cr)
0.77
EPS TTM
78.09
Book value
Dividend
0.51%

Invest in Divis Laboratories Ltd at ZERO Brokerage for 30 days

Price Performance

-4.83 %
1 Wk
-2.45 %
1 M
1.63 %
3 M
57.10 %
1 Y
-3.77 %
YTD

Traded Volume Movement

Technical Details

Support 3
5641
Support 2
5701
Support 1
5804
Pivot Point :
5864
Resistance 1
5968
Resistance 2
6027
Resistance 3
6131

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Divis Laboratories Ltd
₹5,907.40(+63.65/1.09%)
5,907.40+63.65155,133.2057.1074.7411.36
Ipca Laboratories Ltd
₹1,477.60(+13.70/0.94%)
1,477.60+13.7037,139.7626.7853.165.50
Lupin Ltd
₹1,995.00(+25.10/1.27%)
1,995.00+25.1089,922.1922.2228.734.09
J B Chemicals & Pharmaceuticals Ltd
₹1,665.00(-4.30/-0.26%)
1,665.00-4.3025,975.36-0.4041.258.21
338.40+2.001,974.85-17.3120.301.19
Sanofi India Ltd
₹5,272.00(+122.25/2.37%)
5,272.00+122.2511,859.87-42.2328.2217.38

About Divis Laboratories Ltd

Divis Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 154939.41 crores. It has reported a sales of Rs. 2297 crores and a net profit of Rs. 594 crores for the quarter ended December 2018. The company management includes Ramesh B V Nimmagadda, Murali K Divi,N V Ramana,Kiran S Divi,K V K Seshavataram,Ramesh B V Nimmagadda,Nilima Motaparti,S Ganapaty,Sunaina Singh,Kosaraju Veerayya Chowdary,Satish Choudhury,S. Devendra Rao,Rajendrakumar Premchand Shah (Divis Laboratories Ltd) among others.
Chairman
Ramesh B V Nimmagadda
Registered office
1-72-23(P)/DIVIS/303 Divi Towe,Cyber Hills Gachibowli,Hyderabad,Telangana,500032
FAX :91-40-23786460
Background
Incorporation Year1990
Face Value₹2
Market Lot1

Latest News

Nifty 50 earnings growth remains sluggish for third straight quarter: M.O.

The earnings season for the October-December period marked the third consecutive quarter of low single-digit earnings growth, leaving analysts and investors wanting for more. Domestic brokerage Motilal Oswal noted that the slowdown in earnings growth has coincided with the ongoing market correction, as the Nifty 50 has recorded a 4 percent PAT growth in 9MFY25.
17 Feb 2025 | 10:27 AM

📢 Sensex plunges 627 points at the open; Nifty below 22,750

📈 Amid weak global cues, domestic benchmark indices started gap-down on 17 February, 2025.
📢 At 9:16 AM, the Sensex tanked 626.89 points or 0.83% at 75,312.32, and the Nifty plunged 195.70 points or 0.85% at 22,733.55.
📊 Oil India (⬇️4.00%), Aditya Birla FRL (⬇️3.07%) and PB Fintech (⬇️4.70%) appeared as the top losers on the Nifty 50 at the Open. A, B and C stocks are in focus today.
17 Feb 2025 | 09:30 AM

📢 Sensex plunges 627 points at the open; Nifty below 22,750

📈 Amid weak global cues, domestic benchmark indices started gap-down on 17 February, 2025.
📢 At 9:16 AM, the Sensex tanked 626.89 points or 0.83% at 75,312.32, and the Nifty plunged 195.70 points or 0.85% at 22,733.55.
📊 Oil India (⬇️4.00%), Aditya Birla FRL (⬇️3.07%) and PB Fintech (⬇️4.70%) appeared as the top losers on the Nifty 50 at the Open. A, B and C stocks are in focus today.
17 Feb 2025 | 09:30 AM

Borosil Renewable shares hit 5% lower circuit as losses widen in Q3

Shares of Borosil Renewables were locked in the 5 percent lower circuit on February 17 after the company's net losses widened on year in the December quarter. The company's net loss swelled up to Rs 30 crore for the December quarter, a sharp downturn from a loss of Rs 15.90 crore in the same period last year.
17 Feb 2025 | 01:02 PM

ICRA Standalone December 2024 Net Sales at Rs 70.83 crore

Reported Standalone quarterly numbers for ICRA are: Net Sales at Rs 70.83 crore in December 2024 up 10.05% from Rs. 64.36 crore in December 2023. Quarterly Net Profit at Rs. 31.10 crore in December 2024 up 53.93% from Rs. 20.20 crore in December 2023. EBITDA stands at Rs. 42.08 crore in December 2024 up 50.29% from Rs. 28.00 crore in December 2023.
17 Feb 2025 | 01:01 PM

How to buy Divis Laboratories Ltd shares on nse?

To buy Divis Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Divis Laboratories Ltd share price today?

The Divis Laboratories Ltd shares price on nse is Rs.5907.4 today.

What is the market cap of Divis Laboratories Ltd shares on NSE ?

The company has a market capitalization of Rs.155133.20Cr

What is the PE & PB ratio of Divis Laboratories Ltd shares ?

PE is 74.74 and PB is 11.36

What is the 52 Week High and Low of Divis Laboratories Ltd shares?

Divis Laboratories Ltd stock price high: Rs.6285.45 Divis Laboratories Ltd stock price low: Rs.3350